Jonathan Wade Goldman

机构：Santa Monica College, University of California, Los Angeles, University of California System, University of Colorado Cancer Center, UCLA Jonsson Comprehensive Cancer Center, University of Colorado Denver · ORCID：0000-0002-4925-8243

发表论文 792 篇 · 总被引 35596 次 · h-index 68

代表论文

• Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non–Small Cell Lung Cancer (2025 · Journal of Clinical Oncology · 被引 13)
• Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report (2025 · Journal of Thoracic Oncology · 被引 6)
• NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026 (2026 · Journal of the National Comprehensive Cancer Network · 被引 3)
• Osimertinib plus Gefitinib in Patients with EGFR -Mutated Advanced Non–Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD (2026 · Clinical Cancer Research · 被引 1)
• Data from Genomic Profiling of Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung Cancer after Progression on First-line Osimertinib: Phase II ORCHARD Study (2026)
• Supplementary Data from Genomic Profiling of Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung Cancer after Progression on First-line Osimertinib: Phase II ORCHARD Study (2026)